Search | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Displaying 2 results.

- Speech
Ancestim (stem cell factor, SCF) in combination with filgrastim can mobilize sufficient peripheral blood progenitor cells (PBPC) to support high-dose salvage chemotherapy and late intensification in relapsing and refractory aggressive non-Hodgkin's lymphoma. A GELA study.
Haioun, C. Ferrant, Augustin[UCL] Van Hoof, A. Thieblemont, C Hulin, C. Mounier, N. Tilly, H. Sebban, C. Allain, A Lepage, E. Osselaer, Jean-Claude[UCL] Beaujean, F Vannerom, H Cailliot, C Bosly, André[UCL] (2003) 45th Annual Meeting of the American-Society-of-Hematology — SAN DIEGO (California)
- Speech
A randomized pilot clinical trial comparing 5 versus 10 mu g/kg filgrastim (Neupogen) after FEC chemotherapy in order to collect peripheral blood stem cells (PBSC)
Dhondt, Linda[UCL] Humblet, Yves[UCL] André, Marc Guillaume, T. Feyens, Anne Marie[UCL] Canon, JL. Doyen, Chantal Longueville, Jacques[UCL] Vannerom, H Symann, Michel[UCL] (1995) —